The Clinical Utility of CMV specific IGRAs for Determining Protection Against CMV

Track: BMT Tandem "Scientific" Meeting
Friday, February 13, 2015, 12:30 PM-1:30 PM
Seaport A-E (Manchester Grand Hyatt)
Deepali Kumar, MD, MSc , Toronto General Hospital, Toronto, ON, Canada
Presentation recording not available for download or distribution as requested by the presenting author.
Disclosures:
D. Kumar, Roche, GSK, Investigator: Research Grant
Merck, Speaker: Honoraria
Oxford Immunotec, Pfizer, Advisory, Board Member & Speaker: Honoraria
See more of: BMT Tandem Luncheon Symposium: The Role of IGRAs in Immunocompromised Patients: Predicting CMV Infection and Diagnosing Latent or Active TB
See more of: BMT Tandem "Scientific" Meeting
<< Previous Presentation | Next Presentation